Skip to main content
. 2022 Nov 10;86:104330. doi: 10.1016/j.ebiom.2022.104330

Table 3.

Multivariate analysis of plasma HIV RNA during and post-intervention period.

Models Variables Coefficient 95% CI P-value
Model 1.
Intervention period
(week 4–16)
Intercept 2.013 0.810 3.216 0.001
log plasma HIV RNA at week 4 0.672 0.385 0.959 <0.001
Ingestible sensor (ref: UC) 0.851 −0.912 2.614 0.341
Average adherence at weeks 4, 8, 12,16 −1.512 −2.740 −0.284 0.016
IS∗Adherence −0.882 −2.847 1.082 0.375
Model 2.
Post-intervention period (week 16–28)
Intercept 2.964 1.418 4.510 <0.001
Log plasma HIV RNA at week 16 0.532 0.256 0.807 <0.001
Ingestible sensor (ref: UC) −0.734 −3.180 1.713 0.553
Average adherence at weeks 16, 20, 24, 28 −2.073 −3.587 −0.560 0.008
IS∗Adherence 0.670 −2.013 3.352 0.621
Model 3.
Longitudinal mixed-effects (week 4–28)
Intercept 1.722 1.231 2.219 <0.001
Week −0.003 −0.030 0.023 0.799
Week2 0.0003 −0.001 0.001 0.454
Ingestible sensor (ref: UC) −0.726 −1.365 −0.081 0.028
Weekly adherence −0.423 −0.900 0.048 0.082
IS∗Adherence 0.723 0.024 1.413 0.042
Baseline log plasma HIV RNA 0.274 0.188 0.360 <0.001

IS, ingestible sensor; UC, usual care.